13th May 2015 07:00
13 May 2015
Optibiotix Health Plc
Notice of Results
Analyst Briefing
OptiBiotix Health plc (AIM: OPTI), a Life Sciences business developing compounds to tackle obesity, high cholesterol and diabetes, will announce its results for the year ended 30 November 2014 on Friday 29 May 2015.
A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 9.30am on Friday 29 May 2015.
If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email [email protected].
For further information:
OptiBiotix Health plc | www.optibiotix.com |
Stephen O'Hara, Chief Executive | Contact via Walbrook below |
Cairn Financial Advisers LLP | Tel: 020 7148 7900 |
Liam Murray / Avi Robinson | |
Hybridan LLP (Joint Broker) Claire Louise Noyce |
Tel: 020 3713 4581 |
Peterhouse Corporate Finance Ltd (Joint Broker) | Tel: 020 7469 0936 |
Lucy Williams / Duncan Vasey | |
Walbrook PR Ltd | Tel: 020 7933 8780 or [email protected] |
Anna Dunphy | Mob: 07876 741 001 |
Mike Wort | Mob: 07900 608 002 |
Related Shares:
OptiBiotix Health